Nu Skin Enterprises, Inc. Stock Swiss Exchange

Equities

NUS

US67018T1051

Personal Products

End-of-day quote Swiss Exchange 5-day change 1st Jan Change
- CHF -.--% Intraday chart for Nu Skin Enterprises, Inc. -.--% -.--%

Financials

Sales 2024 * 1.77B 1.59B 2.41B Sales 2025 * 1.83B 1.65B 2.49B Capitalization 545M 490M 741M
Net income 2024 * 45M 40.44M 61.24M Net income 2025 * 70M 62.91M 95.26M EV / Sales 2024 * 0.42 x
Net Debt 2024 * 192M 173M 261M Net Debt 2025 * 96.6M 86.81M 131M EV / Sales 2025 * 0.35 x
P/E ratio 2024 *
12.1 x
P/E ratio 2025 *
7.67 x
Employees -
Yield 2024 *
2.19%
Yield 2025 *
2.19%
Free-Float 53.65%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 50 15-09-07
Founder 67 83-12-31
Founder 70 83-12-31
Members of the board TitleAgeSince
Founder 70 83-12-31
Founder 67 83-12-31
Director/Board Member 79 08-05-31
More insiders
Nu Skin Enterprises, Inc. is an integrated beauty and wellness company. The Company develops and distributes a comprehensive line of beauty and wellness solutions in approximately 50 markets worldwide. The Company has three brands, Nu Skin, a beauty brand; Pharmanex, a wellness brand; and ageLOC, an anti-aging brand. It develops and distributes products in two categories, beauty products and wellness products. The Company operates through seven segments: Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, which includes Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, which also includes Macau; and Europe, Middle East and Africa, which includes markets in Europe, as well as Israel and South Africa. The Company’s Rhyz strategic investment arm also includes two additional segments: Manufacturing and Rhyz other.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
10.97 USD
Average target price
12.83 USD
Spread / Average Target
+16.99%
Consensus